Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA

por Olson, Amy L., Maher, Toby M., Acciai, Valentina, Mounir, Baher, Quaresma, Manuel, Zouad-Lejour, Leila, Wells, Christopher D., De Loureiro, Lou
Publicado 2020

Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat(®) fixed-dose combination for chronic obstructive pulmonary dis...

por Selya-Hammer, Carl, Gonzalez-Rojas Guix, Nuria, Baldwin, Michael, Ternouth, Andrew, Miravitlles, Marc, Rutten-van Mölken, Maureen, Goosens, Lucas M.A., Buyukkaramikli, Nasuh, Acciai, Valentina
Publicado 2016

Regolazione del prezzo e rimborso dei farmaci: comparatori, endpoint e ruolo della costo-efficacia

por Jommi, Claudio, Apolone, Giovanni, Scroccaro, Giovanna, Acciai, Valentina, Addis, Antonio, Ardizzoni, Andrea, Bernardini, Renato, Bortolami, Alberto, Brigido, Alessia, Buzzetti, Giuliano, Canonico, Pier Luigi, Caprari, Francesca, Centanni, Stefano, Cernetti, Chiara, Cicchetti, Americo, Corsico, Giorgio, Damele, Francesco, de Braud, Filippo, Manurita, Sara, Mennini, Francesco Saverio, Olivi, Irene, Parretta, Federica, Pippo, Lara, Pulimeno, Stefania, Riccaboni, Massimo, Rossi, Giuseppe, Saleri, Cecilia, Sinibaldi, Alessandra, Spandonaro, Federico, Stefenoni, Cristian, Visentin, Elena, Viale, Pierluigi, Zapparelli, Giuseppina, Popoli, Patrizia
Publicado 2022